Canopy Growth Corporation CGC Business Segments
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Cannabis | $53.49M0.0% | $53.49M0.0% | $53.49M0.0% | $53.49M+14.6% | $46.68M0.0% | |
| Storz And Bickel | $16.78M-26.7% | $22.89M+44.6% | $15.83M+4.5% | $15.15M-22.4% | $19.52M-22.1% | |
| Revenue (Gross) by Product | ||||||
| Canadian Adult Use Cannabis | $20.58M-10.2% | $22.93M-4.2% | $23.94M-11.4% | $27.02M+32.4% | $20.4M-3.5% | |
| Canadian Medical Cannabis | $25.28M+12.3% | $22.51M+3.2% | $21.82M+2.9% | $21.21M+6.2% | $19.97M+2.0% | |
| International Markets Cannabis | $8.6M+38.5% | $6.21M+22.0% | $5.09M-41.9% | $8.76M+70.6% | $5.13M-42.8% | |
| Storz Bickel | $16.78M-26.7% | $22.89M+44.6% | $15.83M+4.5% | $15.15M-22.4% | $19.52M-22.1% | |
| Revenue by Geography | ||||||
| CA | $46.67M+2.7% | $45.44M-0.7% | $45.76M-5.1% | $48.23M+19.3% | $40.43M-0.7% | |
| DE | $15.77M-17.9% | $19.2M+50.9% | $12.73M-11.5% | $14.38M+15.5% | $12.45M-29.8% | |
| US | $7.25M-16.4% | $8.67M+36.1% | $6.37M+6.7% | $5.97M-29.5% | $8.48M-26.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Canopy Growth Corporation break its business down?
- Canopy Growth Corporation (CGC) reports revenue by business across 2 parts — Cannabis and Storz And Bickel. Each is extracted from the segment footnotes and tracked over time.
- Where does Canopy Growth Corporation's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Canopy Growth Corporation's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
